Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Autor principal: | Tania, Umme |
---|---|
Outros Autores: | Khan, Tanisha |
Formato: | Tese |
Idioma: | English |
Publicado em: |
Brac University
2023
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/18736 |
Registros relacionados
-
A review on targeted therapies for lung cancer
por: Ashraf, Anushey
Publicado em: (2023) -
Molecules associated with the development of lung cancer
por: Rahman, Adree, et al.
Publicado em: (2023) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
por: Paul, Pulock
Publicado em: (2024) -
Protein biomarkers for Lung Cancer: a bioinformatic approach
por: Jeba, Joynob
Publicado em: (2017) -
Potential of liposomes for the treatment of lung cancer- a review
por: Mim, Shanzida
Publicado em: (2023)